SDC1 and Miyoshi myopathy: A seminal investigation by Jiang and colleagues [125] demonstrated that NK-92MI cells (IL-2-independent derivative cell line of NK-92) engineered to express a CD138-specific CAR effectively recognized and killed CD138+ MM cell lines (RPMI8226, U266 and NCI-H929).